{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:53:17Z","timestamp":1781797997414,"version":"3.54.5"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Syringe service programs (SSPs) deliver evidence-based harm reduction interventions to persons who inject drugs to reduce morbidity and mortality in this population, including syringe exchange, naloxone distribution, linkage to medications for opioid use disorder, and other services. In July 2025, a federal executive order threatened federal support for SSPs in the US.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To estimate the potential long-term outcomes of halting federal funding for SSPs.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This decision analytical model study used a closed cohort microsimulation model of the natural history of injection drug use and health outcomes among persons who inject drugs in the US from August 1, 2025, to August 2030. The model was populated with data from the Centers for Disease Control and Prevention\u2019s National HIV Behavioral Surveillance system and published data to create representative cohorts of persons who inject drugs nationwide.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Cases in which total funding for SSPs was reduced by 11% and 80% were modeled. Within each case, 3 potential scenarios related to federal funding disruptions due to an executive order threatening funding for SSPs were modeled: (1) funding disruptions remain in place for 5 years, through August 2030; (2) funding returns to previous levels after 1 year, in August 2026; and (3) funding returns to 100% of previous levels in January 2029.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes<\/jats:title>\n The primary outcome was 5-year all-cause and overdose mortality and nonfatal overdoses.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n In a hypothetical study population of 3\u202f694\u202f500 persons who inject drugs (57.0% male; mean [SD] age, 49.5 [17.5] years), all-cause mortality increased by 0.1% (95% credible interval [CrI], 0-0.2%) to 5.0% (95% CrI, 0-0.8%), overdose mortality increased by 0.2% (95% CrI, \u22120.1% to 0.4%) to 6.9% (95% CrI, \u22124.3% to 14.4%), and nonfatal overdoses decreased by 0.1% (95% CrI, \u22120.2% to 0) to 4.2% (95% CrI, \u22127.8% to 0.1%) during 5 years across all scenarios. The worst-case scenario, in which there was sustained high levels of service disruption, resulted in 39\u202f600 additional deaths and 15\u202f600 additional overdose deaths among persons who inject drugs in the US. All-cause mortality and overdose mortality increased in most sensitivity analyses.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this decision analytical model study estimating the effects of reducing federal funding for SSPs, the findings suggest that mortality will increase among persons who inject drugs during the 5 years after loss of funding. Future studies are needed to understand clinical effects of funding changes.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.19402","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:00:37Z","timestamp":1781794837000},"page":"e2619402","source":"Crossref","is-referenced-by-count":0,"title":["Projected Outcomes of Reducing Federal Funding for Syringe Service Programs via Executive Order"],"prefix":"10.1001","volume":"9","author":[{"given":"Kirk B.","family":"Fetters","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Division of General Internal Medicine, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Yamkovoy","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Division of General Internal Medicine, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Guan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Division of General Internal Medicine, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Scott","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Kerr","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Division of General Internal Medicine, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Denver Health and Hospital Authority, Denver, Colorado"},{"name":"Department of Emergency Medicine, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenyth L.","family":"Day","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Plesons","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler S.","family":"Bartholomew","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansel E.","family":"Tookes","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia","family":"Al-Tayyib","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Public Health Institute at Denver Health, Denver Health and Hospital Authority, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Barocas","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Division of General Internal Medicine, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"522","key":"zoi260538r1","first-page":"1","article-title":"Drug overdose deaths in the United States, 2003-2023.","volume":"1","author":"Garnett","year":"2024","journal-title":"NCHS Data Brief"},{"issue":"4","key":"zoi260538r2","first-page":"1","article-title":"Deaths: final data for 2022.","volume":"1","author":"Xu","year":"2025","journal-title":"Natl Vital Stat Rep"},{"issue":"9","key":"zoi260538r4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012021.pub2","article-title":"Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.","volume":"9","author":"Platt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"zoi260538r5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ije\/dyt243","article-title":"Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.","volume":"43","author":"Aspinall","year":"2014","journal-title":"Int J Epidemiol"},{"key":"zoi260538r6","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"zoi260538r7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227298","article-title":"The effectiveness of substance use interventions for homeless and vulnerably housed persons: A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder.","volume":"15","author":"Magwood","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"zoi260538r8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","article-title":"Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews.","volume":"17","author":"Fernandes","year":"2017","journal-title":"BMC Public Health"},{"issue":"9068","key":"zoi260538r9","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/S0140-6736(96)11380-5","article-title":"Effectiveness of needle-exchange programmes for prevention of HIV infection.","volume":"349","author":"Hurley","year":"1997","journal-title":"Lancet"},{"key":"zoi260538r10","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.749033","article-title":"Effectiveness of interventions for prevention of common infections among opioid users: a systematic review of systematic reviews.","volume":"10","author":"Puzhko","year":"2022","journal-title":"Front Public Health"},{"issue":"4","key":"zoi260538r11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2105\/AJPH.2024.307583","article-title":"Funding and delivery of syringe services programs in the United States, 2022.","volume":"114","author":"Facente","year":"2024","journal-title":"Am J Public Health"},{"issue":"4","key":"zoi260538r12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216205","article-title":"Estimated cost of comprehensive syringe service program in the United States.","volume":"14","author":"Teshale","year":"2019","journal-title":"PLoS One"},{"key":"zoi260538r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2025.100355","article-title":"On-site health service delivery models at syringe services programs in the United States: results of a national cross-sectional survey.","volume":"16","author":"Behrends","year":"2025","journal-title":"Drug Alcohol Depend Rep"},{"issue":"5","key":"zoi260538r14","doi-asserted-by":"publisher","first-page":"e673","DOI":"10.1016\/S2214-109X(23)00058-X","article-title":"Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review.","volume":"11","author":"Colledge-Frisby","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"1","key":"zoi260538r15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/09581591003653124","article-title":"The biopolitics of needle exchange in the United States.","volume":"21","author":"McLean","year":"2011","journal-title":"Crit Public Health"},{"issue":"1_suppl","key":"zoi260538r18","doi-asserted-by":"publisher","first-page":"10S","DOI":"10.1177\/0033354920936233","article-title":"Making the case for syringe services programs.","volume":"135","author":"Adams","year":"2020","journal-title":"Public Health Rep"},{"issue":"6","key":"zoi260538r20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/QAD.0000000000003199","article-title":"The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: a modeling study.","volume":"36","author":"Zang","year":"2022","journal-title":"AIDS"},{"issue":"10500","key":"zoi260538r23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(25)01186-9","article-title":"Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030: a retrospective impact evaluation and forecasting analysis.","volume":"406","author":"Cavalcanti","year":"2025","journal-title":"Lancet"},{"issue":"17","key":"zoi260538r24","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2023.4800","article-title":"Population-level health effects of involuntary displacement of people experiencing unsheltered homelessness who inject drugs in US cities.","volume":"329","author":"Barocas","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"zoi260538r25","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1016\/S2468-2667(21)00248-6","article-title":"Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study.","volume":"7","author":"Barocas","year":"2022","journal-title":"Lancet Public Health"},{"key":"zoi260538r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2024.100757","article-title":"Comparing harm reduction and overdose response services between community-based and public health department syringe service programmes using a national cross-sectional survey.","volume":"34","author":"Ray","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"zoi260538r28","doi-asserted-by":"publisher","DOI":"10.1056\/CAT.23.0341","article-title":"NYC\u2019s overdose prevention centers: data from the first year of supervised consumption services.","author":"McAteer","year":"2024","journal-title":"NEJM Catal"},{"issue":"73","key":"zoi260538r30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugpo.2019.07.030","article-title":"The prevalence of non-fatal overdose among people who inject drugs: a multi-stage systematic review and meta-analysis.","volume":"73","author":"Colledge","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"1","key":"zoi260538r31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/add.16320","article-title":"Drug consumption rooms are effective to reduce at-risk practices associated with HIV\/HCV infections among people who inject drugs: results from the COSINUS cohort study.","volume":"119","author":"Lalanne","year":"2024","journal-title":"Addiction"},{"issue":"1","key":"zoi260538r32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cid\/ciac543","article-title":"Estimated number of people who inject drugs in the United States.","volume":"76","author":"Bradley","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi260538r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.55965","article-title":"Health, costs, and injection-related infections at a hypothetical overdose prevention center.","volume":"9","author":"Padmanabhan","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi260538r34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/ajad.13540","article-title":"Impact of inpatient addiction psychiatry consultation on opioid use disorder outcomes.","volume":"33","author":"Kast","year":"2024","journal-title":"Am J Addict"},{"issue":"3","key":"zoi260538r35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/ADM.0000000000001095","article-title":"Associations between distinct co-occurring substance use disorders and receipt of medications for opioid use disorder in the Veterans Health Administration.","volume":"17","author":"Frost","year":"2023","journal-title":"J Addict Med"},{"issue":"2","key":"zoi260538r36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/ADM.0000000000000851","article-title":"Inpatient opioid use disorder treatment by generalists is associated with linkage to opioid treatment programs after discharge.","volume":"16","author":"Tierney","year":"2022","journal-title":"J Addict Med"},{"issue":"12","key":"zoi260538r37","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1097\/QAD.0000000000003629","article-title":"Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections.","volume":"37","author":"Rosenthal","year":"2023","journal-title":"AIDS"},{"issue":"2","key":"zoi260538r39","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/S2468-2667(23)00300-6","article-title":"Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis.","volume":"9","author":"Rammohan","year":"2024","journal-title":"Lancet Public Health"},{"issue":"1","key":"zoi260538r40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13722-023-00394-x","article-title":"Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature.","volume":"18","author":"Jakubowski","year":"2023","journal-title":"Addict Sci Clin Pract"},{"key":"zoi260538r41","doi-asserted-by":"publisher","first-page":"138S","DOI":"10.1177\/0033354920930137","article-title":"The impact of syringe services program policy on risk behaviors among persons who inject drugs in 3 US cities, 2005-2015.","volume":"135","author":"Nassau","year":"2020","journal-title":"Public Health Rep"},{"issue":"12","key":"zoi260538r42","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.2105\/AJPH.2018.304673","article-title":"Estimated prevalence of opioid use disorder in Massachusetts, 2011-2015: a capture-recapture analysis.","volume":"108","author":"Barocas","year":"2018","journal-title":"Am J Public Health"},{"issue":"5","key":"zoi260538r44","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.1262","article-title":"Experience of personal loss due to drug overdose among US adults.","volume":"5","author":"Kennedy-Hendricks","year":"2024","journal-title":"JAMA Health Forum"},{"key":"zoi260538r46","doi-asserted-by":"publisher","DOI":"10.1177\/21501319221147246","article-title":"The effect of naloxone access laws on fatal synthetic opioid overdose fatality rates.","volume":"14","author":"Tabatabai","year":"2023","journal-title":"J Prim Care Community Health"},{"issue":"1","key":"zoi260538r47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12954-023-00755-4","article-title":"How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study.","volume":"20","author":"Lambdin","year":"2023","journal-title":"Harm Reduct J"},{"issue":"1","key":"zoi260538r48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12954-020-00376-1","article-title":"Hospital admissions among people who inject opioids following syringe services program implementation.","volume":"17","author":"Bornstein","year":"2020","journal-title":"Harm Reduct J"},{"key":"zoi260538r49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.02.024","article-title":"Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs.","volume":"162","author":"Caudarella","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"zoi260538r38","volume-title":"Evidence-based Synthesis Program Reports: Effectiveness of Syringe Services Programs: A Systematic Review","author":"Mackey","year":"2023"},{"key":"zoi260538r43","author":"Substance Abuse and Mental Health Services Administration","year":"2024"},{"key":"zoi260538r3","unstructured":"Ahmad? FB, Cisewski? JA, Rossen? LM, Sutton? P. Provisional drug overdose death counts. National Center for Health Statistics. Updated April 15, 2026. Accessed May 13, 2026. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"zoi260538r16","unstructured":"Consolidated Appropriations Act, HR 2029, 114th Congress (2016). Accessed October 17, 2025. https:\/\/www.congress.gov\/bill\/114th-congress\/house-bill\/2029\/text"},{"key":"zoi260538r17","unstructured":"Department of Health and Human Services implementation guidance to support certain components of syringe services programs, 2016. March 29, 2016. Centers for Disease Control and Prevention. Accessed May 13, 2026. https:\/\/www.cdc.gov\/syringe-services-programs\/media\/pdfs\/2024\/04\/hhs-ssp-guidance.pdf"},{"key":"zoi260538r19","unstructured":"Javed? Z, Burk? K, Facente? S, Pegram? L, Ali? A, Asher? A. Syringe services programs: a technical package of effective strategies and approaches for planning, design, and implementation. 2020. Accessed October 17, 2025. https:\/\/stacks.cdc.gov\/view\/cdc\/105304"},{"key":"zoi260538r21","unstructured":"Ending crime and disorder on America\u2019s streets. Fed Regist. 2025;90(143):35817-35820. Accessed May 13, 2026 https:\/\/www.federalregister.gov\/documents\/2025\/07\/29\/2025-14391\/ending-crime-and-disorder-on-americas-streets"},{"key":"zoi260538r22","unstructured":"Dear Colleague Letter on Executive Order on Ending Crime and Disorder on America\u2019s Streets. July 29, 2025. Accessed September 22, 2025. https:\/\/www.samhsa.gov\/about\/news-announcements\/dear-colleague"},{"key":"zoi260538r27","unstructured":"HIV infection risk, prevention, and testing behaviors among persons who inject drugs\u2014National HIV Behavioral Surveillance, 20 US cities, 2022.? Centers for Disease Control and Prevention. February 1, 2024. Accessed May 13, 2026. https:\/\/stacks.cdc.gov\/view\/cdc\/150464"},{"key":"zoi260538r29","doi-asserted-by":"crossref","unstructured":"Shealey? JY, Hall? EW, Pigott? TD, . Systematic review and meta-analysis to estimate the burden of non-fatal and fatal overdose among people who inject drugs living in the U.S. and comparator countries: 2010-2023.? medRxiv. Preprint posted online August 20, 2024. doi:10.1101\/2024.08.14.24310813?","DOI":"10.1101\/2024.08.14.24310813"},{"key":"zoi260538r45","unstructured":"Sparks? G, Montero? A, Kirzinger? A, Valdes? I, Hamel? L. KFF Tracking Poll July 2023: substance use crisis and accessing treatment. August 15, 2023. Accessed November 2, 2025. https:\/\/www.kff.org\/other-health\/kff-tracking-poll-july-2023-substance-use-crisis-and-accessing-treatment\/#b1493bab-8c08-4113-8a94-ad679dc8920e--key-findings"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2850494\/fetters_2026_oi_260538_1781126684.72038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:00:46Z","timestamp":1781794846000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2850494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.19402","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}